Literature DB >> 20960245

Different effects of α- and γ-polymorphs of glycine on behavior of GC rats predisposed to catalepsy.

A L Markel1, A F Achkasov, O I Prokudina, T A Alekhina, E V Boldyreva, V V Boldyrev.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20960245     DOI： 10.1134/S1607672910050042

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  5 in total

1.  The metabolic response to ingested glycine.

Authors:  Mary C Gannon; Jennifer A Nuttall; Frank Q Nuttall
Journal:  Am J Clin Nutr       Date:  2002-12       Impact factor: 7.045

2.  Neuroprotective effects of glycine for therapy of acute ischaemic stroke.

Authors:  E I Gusev; V I Skvortsova; S A Dambinova; K S Raevskiy; A A Alekseev; V G Bashkatova; A V Kovalenko; V S Kudrin; E V Yakovleva
Journal:  Cerebrovasc Dis       Date:  2000 Jan-Feb       Impact factor: 2.762

3.  Amelioration of negative symptoms in schizophrenia by glycine.

Authors:  D C Javitt; I Zylberman; S R Zukin; U Heresco-Levy; J P Lindenmayer
Journal:  Am J Psychiatry       Date:  1994-08       Impact factor: 18.112

4.  [Selection of Wistar rats for predisposition to catalepsy].

Authors:  N N Barykina; I L Chepkasov; T A Alekhina; V G Kolpakov
Journal:  Genetika       Date:  1983-12

5.  Protective effect of glycine supplementation on the levels of lipid peroxidation and antioxidant enzymes in the erythrocyte of rats with alcohol-induced liver injury.

Authors:  R Senthilkumar; M Sengottuvelan; N Nalini
Journal:  Cell Biochem Funct       Date:  2004 Mar-Apr       Impact factor: 3.685
  5 in total
  1 in total

1.  Effect of α- and γ-polymorphs of glycine on the intranasal delivery of manganese hydroxide nanoparticles into brain structures.

Authors:  A F Achkasov; E V Boldyreva; V I Bukhtiyarov; T A Zapara; E A Losev; M P Moshkin; A S Ratushnyak; A V Romashchenko; S Yu Troitskii; V V Boldyrev
Journal:  Dokl Biochem Biophys       Date:  2014-03-16       Impact factor: 0.788
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.